Metraipolis › archive › dc_7fac3acb456e
KRAS Mutations Predict Inferior Post-Remission Outcomes in Newly Diagnosed Acute Myeloid Leukemia With MAPK Pathway Mutations — Europe PMC PMID:42498507
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42498507
- DOI
- 10.1111/ejh.70270
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-17T20:11:24.008Z
- SHA-256 of the archived text
4087d0fda001d126576f72172139e80bacd7160cffa2df1e5b00c291797bb369- Stable URL of this page
https://metraipolis.com/documento/dc_7fac3acb456e
How to cite
KRAS Mutations Predict Inferior Post-Remission Outcomes in Newly Diagnosed Acute Myeloid Leukemia With MAPK Pathway Mutations — Europe PMC PMID:42498507 — Europe PMC (en), https://europepmc.org/article/MED/42498507 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7fac3acb456e (Metraipolis archive dc_7fac3acb456e, sha256 4087d0fda001d126576f72172139e80bacd7160cffa2df1e5b00c291797bb369)
BibTeX
@misc{dc7fac3acb456e,
title = {KRAS Mutations Predict Inferior Post-Remission Outcomes in Newly Diagnosed Acute Myeloid Leukemia With MAPK Pathway Mutations — Europe PMC PMID:42498507},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42498507},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7fac3acb456e; sha256 4087d0fda001d126576f72172139e80bacd7160cffa2df1e5b00c291797bb369},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42498507. Agents can read the archived copy with the MCP tool read_document.